In particular, higher expression of LAG3 is found in stage I breast cancer (31), predicting the favorable survival in patients with ER- and ER+ breast cancer (65, 92, 93), and longer OS and RFS are associated with higher LAG3 expression in TNBC (29). Here, LAG3 is linked to breast carcinoma.